Pitt-Ohio State Clinical Trials Unit Administrative Supplement

$533,144UM1FY2020AINIH

University Of Pittsburgh At Pittsburgh, Pittsburgh PA

Investigators

John W Mellorscontact Susan L Koletar Sharon Riddler

Linked publications, trials & patents

Paper 39253712 Paper 39247686 Paper 39165724 Paper 39159048 Paper 38938873 Paper 38923420 Paper 38739755 Paper 38684100 Paper 38655842 Paper 38551350 Paper 38489580 Paper 38449916 Paper 38416554 Paper 38381407 Paper 38329130 Paper 38197863 Paper 38180893 Paper 38160309 Paper 38051788 Paper 37910437 Paper 37581929 Paper 37506723 Paper 37503623 Paper 37486775 Paper 37440227 Paper 37439633 Paper 37368931 Paper 37306344 Paper 37183889 Paper 37043527 Paper 36998633 Paper 36966617 Paper 36825498 Paper 36805331 Paper 36792952 Paper 36763044 Paper 36604746 Paper 36596305 Paper 36540980 Paper 36525544 Paper 36462699 Paper 36101518 Paper 36098846 Paper 36039892 Paper 35995785 Paper 35975297 Paper 35730388 Paper 35413022 Paper 35289688 Paper 35223535 Paper 35192655 Paper 35137129 Paper 35018800 Paper 34969254 Paper 34865071 Paper 34794178 Paper 34498980 Paper 34398957 Paper 34398236 Paper 34322136 Paper 34185068 Paper 34136266 Paper 34117753 Paper 33929394 Paper 33901188 Paper 33831911 Paper 33625065 Paper 33564870 Paper 33436439 Paper 33400687 Paper 33382405 Paper 33252493 Paper 33177476 Paper 33174854 Paper 33066718 Paper 32829410 Paper 32823274 Paper 32645162 Paper 32603416 Paper 31822125 Paper 31563942 Paper 31528850 Paper 31487271 Paper 31335587 Paper 31305262 Paper 31299013 Paper 31169770 Paper 31045647 Paper 30928825 Paper 30877580 Paper 30869200 Paper 30864331 Paper 30759997 Paper 30602513 Paper 30590451 Paper 30586364 Paper 30557160 Paper 30535188 Paper 30418519 Paper 30364428

Abstract

The University of Pittsburgh Virology Specialty Laboratory will test various samples provided (nasopharyngeal swabs, throat swabs, and saliva) using EUA approved testing platforms from ThermoFisher and Hologic for patients testing for SARS-CoV-2 to increase the United States testing capacity. Testing volume will depend on sample delivery and test kit availability. Capacity will initially approximate 25-50 samples today, ramping up to 100-200 per day with a sufficient supply chain for reagents. The Ohio State University Medical Center?s Clinical Laboratories are significantly increasing their testing capacity using multiple platforms for PCR and serologic testing (e.g. CDC, DiaSorin, Abbott to name a few). Using the Medical Center?s CLIA-certified testing venues, we propose to develop a protocol to identify, test and obtain clinical history from defined populations who are not in the top tier for priority testing.

View original record on NIH RePORTER →